- In October 2024, Siemens Healthineers announced its collaboration with over 20 industry and public partners, including seven prominent stroke hospitals, to enhance stroke management for patients throughout Europe. The five-year 'UMBRELLA' project, with a total budget of USD 29.30 million, is being funded in part by the Innovative Health Initiative (IHI), a public-private partnership aimed at health research and innovation between the European Union and the life sciences sector in Europe, as well as contributions from industry partners involved in the consortium
- In September 2024, Michigan-based medical device leader Stryker has finalized its acquisition of the Nico Corporation to enhance its neurotechnology and stroke care portfolio. This acquisition includes systems specifically designed for managing surgeries to treat intracerebral hemorrhages (ICH), known as BrainPath and Myriad. By integrating Nico's innovative technologies, Stryker aims to strengthen its offerings in the neurotechnology sector and improve treatment options for patients suffering from stroke-related conditions
- In August 2024, Christian Medical College (CMC) Vellore and IIT Madras unveiled a portable robotic device called PLUTO (Plug-and-Train Robot for Hand Neurorehabilitation) aimed at assisting stroke survivors in their recovery through hand movement therapy. This innovative device is crafted to be both affordable and user-friendly, ensuring accessibility for use in diverse environments such as hospitals, small clinics, community centers, and even at home
- In February 2024, Basking Biosciences, a clinical-stage biopharmaceutical company focused on developing an innovative acute thrombolytic therapy for stroke treatment, announced the completion of a USD 55 million financing round. The round was led by new investor ARCH Venture Partners, with contributions from other new investors including Insight Partners, Platanus, Solas BioVentures, and RTW Investments, alongside existing investors Longview Ventures, Rev1 Ventures, and The Ohio State University
- In May 2022, researchers at Osaka Metropolitan University began exploring robotic therapy as a promising treatment for stroke recovery during its chronic stage. If widely adopted, robotic therapy could enhance stroke patient care by offering a cost-effective solution with minimal need for direct supervision from therapeutic staff
- In April 2022, the U.S. National Institutes of Health (NIH) provided USD 1.8 million in funding for a project aimed at developing artificially grown, simplified mini-organs. These brain-like miniature organs are intended to produce particles that could be harvested for creating new medications targeting brain cells damaged by stroke
